The manifestations of m~ltiple myeloma are protean and related to bony osteolytic lesions, and to medullar and renal insufficiency. We report a patient who presented with otalgia as the inaugural symptom of multiple myeloma. Local irradiation combined with systemic chemotherapy led to the disappearance of the temporal bone mass and the accompanying symptoms. To date, 24 months after the diagnosis, the patient is still in remission.
Introduction
Multiple myeloma (MM) accounts for 10 per cent of haematological malignancies and one per cent of ail cancer-related deaths (Alexian and Dimopulos, 1994; Bataille and Harousseau, 1997) . MM is a neoplastic proliferation of monoclonal plasma cells within the haematopoietic bone marrow. Symptoms are related to these osteolytic lesions (skeletal pain, pathological fractures, hypercaJcaemia), to the replacement of bone marrow by the neoplastic process (immunosuppression resulting in increased bacterial infections, anaemia, bleeding), and to renal insufficiency.
The diagnosis of MM requires at least two of the following criteria (Barlogie, 1995; Selby and Gore, 1995) : 1) serum or urinary monoclonal immunoglobulin which can be composed of the entire immunoglobulin protein, of complete light chains, or various fragments; 2) bonemarrow infiltration by large and immature plasma cells; -3) osteolytic lesions. Several staging systems have been described (Barlogie, 1995; Selby and Gore, 1995) .
Since MM is a systemic illness, involvement of the temporal bone is possible. Nevertheless, otological symptoms in MM have rarely been described. A case is reported in which the presenting signs of MM were otological. The literature on temporal bone involvement in MM is reviewed.
Case report _
A 70-year-old male, without previous medical history, consulted because of progressively worsening right earache of six months duration. He did not complain of hearing loss, tinnitus, or dizziness.
Clinical examination revealed aright external earcanal partially obstructed by a subcutaneous, smooth mass, located on the posterior bony-cartiligenous junction. The tympanic membrane was intact. Tuning fork testing was normal and symmetrical. A right peripheral facial paresis was present.
A temporal bone computed tomography (CT) scan ( Figure la) showed an osteolytic lesion, 2.5 cm in diameter, enhanced by contrast material, and replacing the right mastoid. The mass eroded the posterior canal wall and protruded in the posterior fossa. A second osteolytic lesion was found at the level of the right occipital condyle. These lesions exhibited homogeneous enhancement with gadolinium on magnetic resonance imaging (MRI) (Figure 1b) .
A biopsy of -the external audit ory canal mass was performed under local anaesthesia. The pathology showed a proliferation of atypical plasma cells compatible with a multiple myeloma (Figure 2 ) and immunohistochemical staining was positive for the Kappa light chains and negative for the Lambda light chains (not shown).
Further investigations, including a skull and skeletal X-rays, a protein electrophoresis, an immunoelectrophoresis and a bone marrow biopsy, permitted the diagnosis of IgG-Kappa multiple myeloma, without renal failure, anaemia, or hypercaJcaemia. The disease was th us staged as IlIa.
The patient was treated with Alkeran and Prednisone, and local radiation therapy delivered through two lateral weighted fields for a total dose of 30 Gy (6 MeV photons; 10 fractions of 3 Gy).
Three months after this treatment, the patient was greatly improved. The otalgia and facial paralysis resolved. The external auditory canal lesion regressed completely. Ta date, 24 months after the diagnosis, the patient do es not present any local or general complaints and has resumed his normal activities.
Discussion
A variety of tumours, either primary or secondary, can involve the temporal bone (Hyams, 1987; Abemayor et al., 1988; Kemink et al., 1993) . Symptoms are not specific and tend to vary with the location of the disease pro cess and the invaded anatomical structures (Schuknecht, 1993) . While physicaJ examination, audiological and vestibular investigations are warranted, they are rarely diagnostic and radiological studies such as thin section cr or MRI scans are required to determine the involved structures and help in selecting the surgical approach for excision or biopsy (Jack 1er and Parker, 1992). Involvement of the temporal bone has been reported to occur in the terminal stage of MM. However, at this stage, otological symptoms are overshadowed by the manifestations of diffuse skeletal disease (Schuknecht, 1993) . ln our case, the presenting signs of MM were relatèd to an involvement of the temporal bone. The mastoid mass resulted in otalgia and a facial paIsy without any other otological or systemic symptoms. ln the literature, only a few individu al case reports de scribe a symptomatic MM temporal bone involvement (Table 1) . ln 1979, Lavine et al. presented a patient already diagnosed with MM, who complained of dizziness, hearing loss and tinnitus. Three other cases with otological symptoms in patients with diffuse signs of MM have been published (Shone, 1985; Keay, 1988; Chevalier et al., 1992) . Marks and Brookes in 1985 were the first to describe a patient with left deafness, tinnitus, facial paisy, and intermittent vertigo who had an isolated mastoid lesion. Biopsy of the extemal auditory canal lesion led to the diagn'osis of MM. Funakubo and Kikuchi (1994) describe a similar case. None of these studies included histopathological sections of the temporal bone. Li et al. (1994) studied the temporal bone histopathology in eight patients who had died from advanced, disseminated MM. Among these eight patients only two had otological symptoms, while 14 out of 16 temporal bones (87 per cent) exhibited MM lesions in various locations. The structures involved were exclusively bony, with sparing of mucosa, skin and other key structures such as the facial nerve or the carotid artery. '""'"-=<~.=',,-..;.
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The temporal bone is, therefore, often involved in advanced cases of MM. The dinical expression of this involvement is, however, unusual (Table 1) and only exceptionaIly does MM present with otological symptoms, as in our patient.
